Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
2,100,005
-
Share change
-
-279,711
-
Total reported value
-
$20,140,576
-
Price per share
-
$9.59
-
Number of holders
-
27
-
Value change
-
-$2,990,763
-
Number of buys
-
14
-
Number of sells
-
7
Institutional Holders of REDHILL BIOPHARMA LTD - SPONSORED ADS (RDHL) as of Q1 2017
As of 31 Mar 2017,
REDHILL BIOPHARMA LTD - SPONSORED ADS (RDHL) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,100,005 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, MENORA MIVTACHIM HOLDINGS LTD., Migdal Insurance & Financial Holdings Ltd., BANK HAPOALIM BM, SABBY MANAGEMENT, LLC, Candriam Luxembourg S.C.A., RENAISSANCE TECHNOLOGIES LLC, Psagot Investment House Ltd., INGALLS & SNYDER LLC, and D.A. DAVIDSON & CO..
This page lists
27
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.